Results 271 to 280 of about 133,012 (307)

Oral and long‐acting antipsychotics for relapse prevention in schizophrenia‐spectrum disorders: a network meta‐analysis of 92 randomized trials including 22,645 participants

World Psychiatry, 2022
Giovanni Ostuzzi, Federico Bertolini, Federico Tedeschi   +2 more
exaly  

Effects of antipsychotics on triglyceride trajectories and its implications in CVD: A longitudinal cohort study

EBioMedicine, 2022
Jiqing Li, Shucheng Si, Fuzhong Xue
exaly  

Antipsychotics in the Elderly

Southern Medical Journal, 2007
openaire   +2 more sources

Up-to-date expert opinion on the safety of recently developed antipsychotics

Expert Opinion on Drug Safety, 2020
Laura Orsolini, Domenico De Berardis, Umberto Volpe   +2 more
exaly  

Involvement of Gut Microbiota in Schizophrenia and Treatment Resistance to Antipsychotics

Biomedicines, 2021
Mirko Manchia, Andrea Fontana, Concetta Panebianco   +2 more
exaly  

Antipsychotic Medications

The American Journal of Nursing, 1981
openaire   +2 more sources

New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis

Lancet, The, 2003
Stefan Leucht, Kristian Wahlbeck, Johannes Hamann   +2 more
exaly  

Antipsychotics

Reactions Weekly, 2021
openaire   +2 more sources

Tardive dyskinesia risk with first‐ and second‐generation antipsychotics in comparative randomized controlled trials: a meta‐analysis

World Psychiatry, 2018
Maren Carbon, John M Kane, Stefan Leucht   +2 more
exaly  

Antipsychotics and seizures: Higher risk with atypicals?

Seizure: the Journal of the British Epilepsy Association, 2013
Unax Lertxundi, Juan Medrano, Carmelo Aguirre   +2 more
exaly